• Polyoma BK Virus, PCR, Urine
  • T-Cell Antigen Receptor, Gamma (TRG@) Gene Rearrangement Analysis for Abnormal Clonality, Amplified Method, Bone Marrow
  • Alpha 2 Macroglobulin, Serum
  • Alprazolam, Urine
  • Cotinine, Urine
  • Squamous cell carcinoma of skin
  • Quetiapine, Urine
  • Low Density Lipoprotein Receptor (LDLR) Gene Mutation Analysis
  • D-Dimer
  • Toxoplasma gondii Antibody, IgA
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Interpretation
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.